Visualitza per autor "Romero, Ignacio"
Ara mostrant els elements 1-2 d 2
-
A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors
Poveda, Andres; Oaknin Benzaquen, Ana Mazaltob; Romero, Ignacio; Guerrero‑Zotano, Angel; Fariñas Madrid, Lorena; Rodriguez‑Freixinos, Victor (Nature Research, 2021-02-24) -
Safety and activity of anti-mesothelin antibody–drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study
Santin, Alessandro; González-Martin, Antonio; Moore, Kathleen N; Oaknin Benzaquen, Ana Mazaltob; Romero, Ignacio; Vergote, Ignace (BMJ, 2023-04)